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With the inclusion of Dr. Parvaneh’s name in the authorship, 
the paragraph of Author Contributions should also be corrected 
as follows:
JM, EM, AM, SP, and LN designed the study, interpreted the 
data, and wrote the manuscript; KD, GT, EC, OP, PM, SG, and 
DM performed experiments, acquired and analyzed the data; 
WA-H, CC, MC, JB, CB, DB, SB, TC, JC, VD-C, LOdB, MTdlM, 
GM, AF, RG, RKG, AH, SH, C-HH, MK, AlKi, BK, AnKl, TK, 
BL, VL, MiMa, IM, MeMo, BN, S-YP, NP, AP, SP, IR, JS, RS, TT, 
Y-JK, JW, AG, and SK contributed patient samples and clinical 
and immunological data; all authors have revised the work for 
its intellectual content, have approved its final version and have 
agreed to be accountable for all aspects related to the accuracy 
and integrity of the work.
This correction does not change the scientific conclusions of 
the article in any way.
Author apologizes for these errors and thank you for your 
consideration.
The original has been updated.
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There was a mistake in the authorship. The name of Nima 
Parvaneh was unintentionally omitted. Dr. Parvaneh has con-
tributed biological specimens and clinical and immunological 
data from patient P66 included in the manuscript, and as such he 
should be included in the authorship. The authors apologize for 
the mistake. This error does not change the scientific conclusions 
of the article in any way.
